alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
CERTIFICATIONS

I, Richard Rubin, certify that:

1. I have reviewed this quarterly report of American BiogeneticSciences, Inc.;

2. Based on my knowledge, this report does not contain any untruestatement of a material fact or omit to state a material fact necessary to make thestatements made, in light of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the  issuer as of, and for, theperiods presented in this report;

4. The  issuer's other certifying officer(s) and I are responsiblefor establishing and maintaining disclosure controls and procedures (as 4efined inExchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the  issuer and have:

(a) Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, to ensure thatmaterial information relating to the  issuer, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularly during theperiod in which this report is being prepared;

(b) Designed such internal control over financial reporting, or causedsuch internal control over financial reporting to be designed under our supervision, toprovide reasonable assurance regarding the reliability of financial reporting and thepreparation of financial statements for external purposes in accordance with generallyaccepted accounting principles;

(c) Evaluated the effectiveness of the  issuer's disclosurecontrols and procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of the periodcovered by this report based on such evaluation; and

(d) Disclosed in this report any change in the  issuer's internalcontrol over financial reporting that occurred during the  issuer's most recentfiscal quarter (the  issuer's fourth fiscal quarter in the case of an annual report)that has materially affected, or is reasonably likely to materially affect, the  issuer's internal control over financial reporting; and

5. The  issuer's other certifying officer(s) and I have disclosed,based on our most recent evaluation of internal control over financial reporting, to the  issuer's auditors and the audit committee of the  issuer's board of directors(or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the designor operation of internal control over financial reporting which are reasonably likely toadversely affect the  issuer's ability to record, process, summarize and reportfinancial information; and

(b) Any fraud, whether r not material, that involves management or otheremployees who have a significant role in the  issuer's internal control overfinancial reporting.

Date: November 13, 2009

/s/ Richard RubinCEO, CFO and Chairman
#### § 48.4061(b) [Reserved]
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Gehl
Company's consolidated balance sheet at October 2, 1999 and consolidated
statements of income for the nine-month period ended October 2, 1999 and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                              JAN-1-1999
<PERIOD-END>                                OCT-2-1999
<CASH>                                            3967
<SECURITIES>                                         0
<RECEIVABLES>                                    85002
<ALLOWANCES>                                         0<F1>
<INVENTORY>                                      32119
<CURRENT-ASSETS>                                129129
<PP&E>                                           78925
<DEPRECIATION>                                   44433
<TOTAL-ASSETS>                                  194744
<CURRENT-LIABILITIES>                            59513
<BONDS>                                          30202<F2>
<COMMON>                                           657
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                       95224
<TOTAL-LIABILITY-AND-EQUITY>                    194744
<SALES>                                         222649
<TOTAL-REVENUES>                                222649
<CGS>                                           159115
<TOTAL-COSTS>                                   159115
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                2343
<INCOME-PRETAX>                                  25391
<INCOME-TAX>                                      9014
<INCOME-CONTINUING>                              16377
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     16377
<EPS-BASIC>                                     2.62<F3>
<EPS-DILUTED>                                     2.52
<FN>
<F1>Company presents receivables on a net basis in compliance with Article 10
of Regulation S-X.
<F2>Includes all non-current portion of debt obligations.
<F3>The EPS under the "EPS-Primary" tag represents Basic Earnings Per Share.
</FN>


</TABLE>
I

104TH CONGRESS

1ST SESSION H. R. 1051

To provide for the extension of certain hydroelectric projects located in the

State of West Virginia.

IN THE HOUSE OF REPRESENTATIVES

FEBRUARY 24, 1995

Mr. MOLLOHAN introduced the following bill; which was referred to the

Committee on Commerce

A BILL

To provide for the extension of certain hydroelectric projects

located in the State of West Virginia.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. EXTENSION OF DEADLINE.

4 (a) IN GENERAL.—Notwithstanding the time period

5 specified in section 13 of the Federal Power Act (16

6 U.S.C. 806) that would otherwise apply to Federal Energy

7 Regulatory Commission projects numbered 6901 and

8 6902, the Commission shall, upon the request of the li9 censee for those projects, in accordance with the good

10 faith, due diligence, and public interest requirements of
2

•HR 1051 IH

1 that section, the Commission’s procedures under that sec2 tion, and the procedures specified in that section, extend

3 the time period during which the licensee is required to

4 commence construction of those projects so as to termi5 nate on October 3, 1999.

6 (b) APPLICABILITY.—Subsection (a) shall take effect

7 for the projects upon the expiration of the extension, is8 sued by the Commission under section 13 of the Federal

9 Power Act (16 U.S.C. 806), of the period required for

10 commencement of construction of the projects.

11 (c) REINSTATEMENT OF EXPIRED LICENSE.—If a li12 cense for a project described in subsection (a) has expired

13 prior to the date of enactment of this Act, the Commission

14 shall reinstate the license effective as of the date of its

15 expiration and extend the time required for commence16 ment of construction of the project until October 3, 1999.

Æ
UN PUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 20

- 7342

JOSEPH MICHAEL GRIFFITH,

Plaintiff

- Appellant,

v.

THOMAS K. MAHER,

Defendant

- Appellee

.

Appeal from the United States District Court for the Eastern District of North Carolina , at

Raleigh

. Terrence W. Boyle , District Judge. ( 5:19

- ct

- 03053

- BO )

Submitted : February 18, 2021 Decided: February 23, 2021

Before NIEMEYER, KING, and FLOYD , C ircuit Judges.

Affirmed by un published per curiam opinion

.

Joseph Michael Griffith, Appellant Pro Se.

Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM:

Joseph Michael Griffith appeals the district court’s order denying relief on his 42

U.S.C. § 1983 complaint. We have reviewed the record and find no reversible error.

Accordingly, we affirm for the reasons stated by the district court. Griffith v. Maher , No.

5:19

- ct

- 03053 (E.D .N.C. Aug. 24, 2020). We dispense with oral argument because the

facts and legal contentions are adequately presented in the materials before this court and

argument would not aid the decisional process.

AFFIRMED
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1241 Introduced in House (IH)]

104th CONGRESS
  1st Session
                                H. R. 1241

      To improve the capability to analyze deoxyribonucleic acid.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 15, 1995

 Mr. McCollum introduced the following bill; which was referred to the 
                       Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
      To improve the capability to analyze deoxyribonucleic acid.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``DNA Identification Grants 
Improvement Act of 1995''.

SEC. 2. DNA IDENTIFICATION GRANTS.

    Section 1001(a) of the Omnibus Crime Control and Safe Streets Act 
is amended by striking paragraph (22) and inserting the following:
            ``(22) There are authorized to be appropriated to carry out 
        part X--
            ``(A) $8,000,000 for fiscal year 1996;
            ``(B) $12,000,000 for fiscal year 1997;
            ``(C) $10,000,000 for fiscal year 1998;
            ``(D) $6,000,000 for fiscal year 1999; and
            ``(E) $4,000,000 for fiscal year 2000.''.

SEC. 3. ADVISORY BOARD AND DNA INDEX.

    Section 210306 of the Violent Crime Control and Law Enforcement Act 
of 1994 is amended by striking paragraphs (1) through (5) and inserting 
the following:
            ``(1) $4,000,000 for fiscal year 1996;
            ``(2) $4,500,000 for fiscal year 1997;
            ``(3) $5,000,000 for fiscal year 1998;
            ``(4) $5,500,000 for fiscal year 1999; and
            ``(5) $6,000,000 for fiscal year 2000.''.
                                 <all>
```
Exhibit 99.1
                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
                    AS ADOPTED PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002



              In connection with the Quarterly Report of Worldport
     Communications, Inc. (the "Company") on Form 10-Q for the period ending
     March 31, 2003 as filed with the Securities and Exchange Commission on the
     date hereof (the "Report"), the undersigned Chief Executive Officer and
     Chief Financial Officer of the Company hereby certifies, pursuant to 18
     U.S.C. Section 1350, as adopted pursuant to Section 906 of the
     Sarbanes-Oxley Act of 2002 that, based on her knowledge: i) the Report
     fully complies with the requirements of Section 13(a) or 15(d) of the
     Securities Exchange Act of 1934, and ii) the information contained in the
     Report fairly presents, in all material respects, the financial condition
     and results of operations of the Company as of and for the periods covered
     in the Report.



/s/ Kathleen A. Cote
--------------------
Kathleen A. Cote
Chief Executive Officer and acting Chief Financial Officer


April 30, 2003


                                       31
###### Editorial Note on Subchapter A of Chapter II

#### Editorial Note:

Nomenclature changes to subchapter A appear at 78 FR 60697, Oct. 2, 2013.

#### § 203.14 Scope of the subpart.

This subpart applies to all TT&L depositaries that accept FTD coupons and governs the acceptance and processing of those coupons.
EXHIBIT D

                           CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Quarterly Report of Blackhawk Bancorp, Inc. (the
"Company") on Form 10-QSB for the period ended June 30, 2002 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Todd J.
James, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:

     (1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

      (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

/s/ Todd J. James
-----------------
Todd J. James
Senior Vice President and CFO
August 8, 2002
IN THE SUPREME COURT OF THE STATE OF MONTANA No. DA 1 9 - 0119 IN THE MATTER OF: W.R. , Respondent and Appellant. **ORDER** Upon consideration of Appellant’s motion for extension of time, and good cause appearing, IT IS HEREBY ORDERED that Appellant is granted an extension of time to and including September 25 , 2020, within which to prepare, file, and serve Appellant’s opening brief on appeal.

Electronically signed by: Mike McGrath Chief Justice, Montana Supreme Court

August 20 2020

08/20/2020

Case Number: DA 19-0119
§ 55.6091-1 Place for filing Chapter 44 tax returns. Except as provided in § 55.6091-2 (relating to exceptional cases): ( a ) *In general.* Chapter 44 tax returns shall be filed with any person assigned the responsibility to receive returns in the local Internal Revenue Service office serving the principal place of business or principal office or agency of the real estate investment trust or regulated investment company.
( b ) *Returns filed with service centers or by hand carrying.* Notwithstanding paragraph (a) of this section, unless a return is filed by hand carrying, whenever instructions applicable to Chapter 44 tax returns provide that the returns be filed with a service center, the returns must be so filed in accordance with the instructions. Returns which are filed by hand carrying shall be filed with any person assigned the responsibility to receive hand-carried returns in the local Internal Revenue Service office in accordance with paragraph (a) of this section.
[T.D. 7767, 46 FR 11282, Feb. 6, 1981; 46 FR 15263, Mar. 5, 1981. Redesignated and amended by T.D. 8180, 53 FR 6148, Mar. 1, 1988; T.D. 9156, 69 FR 55746, Sept. 16, 2004]
# L_2019255EN.01000501.xml

| 4.10.2019 | EN | Official Journal of the European Union | L 255/5 |
| --- | --- | --- | --- |

4.10.2019

EN

Official Journal of the European Union

L 255/5

---

COMMISSION IMPLEMENTING REGULATION (EU) 2019/1667

of 27 September 2019

entering a name in the register of protected designations of origin and protected geographical indications ‘Cârnaţi de Pleşcoi’ (PGI)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 1151/2012 of the European Parliament and of the Council of 21 November 2012 on quality schemes for agricultural products and foodstuffs (1), and in particular Article 52(2) thereof,

Whereas:

| (1) | Pursuant to Article 50(2)(a) of Regulation (EU) No 1151/2012, the application from Romania to register the name ‘Cârnaţi de Pleşcoi’ was published in the Official Journal of the European Union (2). |
| --- | --- |

(1)

Pursuant to Article 50(2)(a) of Regulation (EU) No 1151/2012, the application from Romania to register the name ‘Cârnaţi de Pleşcoi’ was published in the Official Journal of the European Union (2).

| (2) | As no statement of opposition under Article 51 of Regulation (EU) No 1151/2012 has been received by the Commission, the name ‘Cârnaţi de Pleşcoi’ should therefore be entered in the register, |
| --- | --- |

(2)

As no statement of opposition under Article 51 of Regulation (EU) No 1151/2012 has been received by the Commission, the name ‘Cârnaţi de Pleşcoi’ should therefore be entered in the register,

HAS ADOPTED THIS REGULATION:

Article 1

The name ‘Cârnaţi de Pleşcoi’ (PGI) is hereby entered in the register.

The name specified in the first paragraph denotes a product in Class 1.2. Meat products (cooked, salted, smoked, etc.) set out in Annex XI to Commission Implementing Regulation (EU) No 668/2014 (3).

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 27 September 2019.

For the Commission,

On behalf of the President,

Phil HOGAN

Member of the Commission

---

(1)  
  OJ L 343, 14.12.2012, p. 1.

1

(2)  
  OJ C 185, 29.5.2019, p. 14.

2

(3)  Commission Implementing Regulation (EU) No 668/2014 of 13 June 2014 laying down rules for the application of Regulation (EU) No 1151/2012 of the European Parliament and of the Council on quality schemes for agricultural products and foodstuffs (OJ L 179, 19.6.2014, p. 36).

3

---
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS NINE MONTHS YEAR-TO-DATE SUMMARY FINANCIAL INFORMATION
EXTRACTED FROM AMERICAN BIOGENETIC SCIENCES, INC. 1997 10-Q FOR THE THIRD
QUARTER ENDED SEPTEMBER 30, 1997
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                       8,164,000
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                    223,000
<CURRENT-ASSETS>                                34,000
<PP&E>                                       1,968,000
<DEPRECIATION>                               1,404,000
<TOTAL-ASSETS>                              10,377,000
<CURRENT-LIABILITIES>                          780,000
<BONDS>                                      2,359,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        20,000
<OTHER-SE>                                   7,218,000
<TOTAL-LIABILITY-AND-EQUITY>                10,377,000
<SALES>                                              0
<TOTAL-REVENUES>                                 9,000
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             2,676,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             878,000
<INCOME-PRETAX>                            (6,041,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (6,041,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (6,041,000)
<EPS-PRIMARY>                                    (.31)
<EPS-DILUTED>                                    (.31)
        

</TABLE>
**EXHIBIT 32.2**

 

**Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted  Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

** **

In connection with the Quarterly Report on Form 10-Q of Merit Medical Systems, Inc. (the “Company”) for the quarter ended March 31, 2010 (the “Report”), I, Kent W. Stanger, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

(1)   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
| Date: May 7, 2010 | /s/ Kent W. Stanger                                     |
|------------------------|---------------------------------------------------------|
|                   | Kent W. Stanger                                         |
|                   | Chief Financial Officer   (principal financial officer) |

 

 

This certification accompanies the foregoing Report pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Registrant for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.  A signed original of this certification has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

1

----
§ 16.18 Authority of the ALJ. ( a ) The ALJ shall conduct a fair and impartial hearing, avoid delay, maintain order, and assure that a record of the proceeding is made.
( b ) The ALJ has the authority to— ( 1 ) Set and change the date, time, and place of the hearing upon reasonable notice to the parties;
( 2 ) Continue or recess the hearing in whole or in part for a reasonable period of time;
( 3 ) Hold conferences to identify or simplify the issues, or to consider other matters that may aid in the expeditious disposition of the proceeding;
( 4 ) Administer oaths and affirmations;
( 5 ) Issue subpoenas requiring the attendance of witnesses and the production of documents at depositions or at hearings;
( 6 ) Rule on motions and other procedural matters;
( 7 ) Regulate the scope and timing of discovery;
( 8 ) Regulate the course of the hearing and the conduct of representatives and parties;
( 9 ) Examine witnesses;
( 10 ) Receive, rule on, exclude, or limit evidence;
( 11 ) Upon motion of a party, take official notice of facts;
( 12 ) Upon motion of a party, decide cases, in whole or in part, by summary judgment where there is no disputed issue of material fact;
( 13 ) Conduct any conference, argument, or hearing on motions in person or by telephone; and
( 14 ) Exercise such other authority as is necessary to carry out the responsibilities of the ALJ under this part.
( c ) The ALJ does not have the authority to make any determinations regarding the validity of Federal statutes or regulations, or Departmental orders, Directives, or other published rules.